Zobrazeno 1 - 3
of 3
pro vyhledávání: '"M.P. Molina-Guillen"'
Autor:
M.P. Molina-Guillen, I Sánchez-Martinez, JC Titos-Arcos, A. Morego Soler, N Manresa-Ramón, MM Sanchez-Catalicio, MC Sanchez-Mulero, B Gil-Rueda, B Arribas-Díaz, A Bosó-Ribelles
Publikováno v:
European Journal of Hospital Pharmacy. 20:A162.1-A162
Background Primary bacteraemia and bacteraemia caused by catheter infections entail a high pharmaceutical cost. The ‘Zero Bacteraemia Project’ (BZP) for central intravenous catheter (CVC) use in invasive therapies showed a decrease in the number
Autor:
A Bosó-Ribelles, MA Moregó-Soler, N Ramón-Manresa, AM Rizo-Cerdá, M Tobaruela-Soto, M.P. Molina-Guillen, B Arribas-Díaz, P Selvi-Sabater, M.M. Sanchez-Catalicio, MC Sanchez-Mulero
Publikováno v:
European Journal of Hospital Pharmacy. 20:A164.1-A164
Background Low therapeutic utility drugs (LTUDs) are those with controversial efficacy that provide little improvement for the disease or the symptoms. These drugs have recently been removed from the system financing Spanish healthcare, with the aim
Autor:
M.D. Nájera-Pérez, A Morego-Soler, M.P. Molina-Guillen, A Bosó-Ribelles, I Sanchez-Quiles, MC Sanchez-Mulero, B Arribas-Díaz, JC Titos-Arcos, J. Pastor-Cano, M.M. Sanchez-Catalicio
Publikováno v:
European Journal of Hospital Pharmacy. 19:181.3-182
Background Linezolid is an antibiotic approved for treatment of nosocomial pneumonia (NP), community-acquired pneumonia (CAP) and complicated skin and soft tissue infections caused by Gram-positive bacteria susceptible to linezolid. Purpose To determ